TriSalus Life Sciences

Yahoo Finance • 27 days ago

TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches

Earnings Call Insights: TriSalus Life Sciences (TLSI) Q3 2025 MANAGEMENT VIEW * CEO Mary Szela reported strong third quarter results, highlighting revenue of $11.6 million, a 57% increase year-over-year and 3% sequential growth. She no... Full story

Yahoo Finance • 4 months ago

TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs

Earnings Call Insights: TriSalus Life Sciences (TLSI) Q2 2025 MANAGEMENT VIEW * CEO Mary T. Szela stated the company delivered $11.2 million in net sales for Q2 2025, marking a 52% year-over-year jump and a 22% sequential increase. She... Full story

Yahoo Finance • 4 months ago

TriSalus study shows promising results for thyroid disease treatment

WESTMINSTER, Colo. - TriSalus Life Sciences Inc. (NASDAQ:TLSI), a $149.46 million market cap medical technology company, announced clinical data showing its Pressure-Enabled Drug Delivery technology demonstrated effectiveness in treating s... Full story

Yahoo Finance • 6 months ago

TriSalus shareholders elect directors, ratify auditor

WESTMINSTER, CO - TriSalus Life Sciences, Inc. (Nasdaq:TLSI), a medical device and pharmaceutical company with a market capitalization of $204 million and significant revenue growth of 46% over the last twelve months, announced the results... Full story